Clinical Trial

Survival Monitoring in Russian Cancer Registries

Study acronym: SURVIMON
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to establish a holistic framework for continuous cancer survival surveillance in Russian regions with high-quality population-based cancer registry data. The data from the population-based cancer registries of the Northwestern regions of Russia will be used to assess net and cause-specific survival trends.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-09-12; most recent amendment 2026-05-12.
Trial Details
NCT Number NCT06043947
Lead Sponsor N.N. Petrov National Medical Research Center of Oncology
Collaborators: European University at St. Petersburg
Conditions Melanoma, Breast Cancer, Oncology, Colon Cancer, Prostate Cancer, Survivorship, Lung Cancer, Cervix Cancer
Enrollment 100,000 participants
Start Date 2023-08-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-15